Antey Group plans to launch a pilot project for the production of innovative products in 2023

The corresponding agreement was signed on the sidelines of the 7th Eastern Economic Forum by the heads of the Antey Group and the ISTC “Russky” Development Fund.

At the pilot site of ISTC “Russky”, Antey Group plans to produce omega-fat and a unique enzyme complex from the hepatopancreas of the Kamchatka crab.

The scope of these innovative products is from veterinary medicine and dermatology to functional nutrition and dietary supplements.

The use of the hepatopancreas of crab for the production of the enzyme complex is due to its high activity: living in extreme conditions and a wide range of nutrition made these enzymes able to break down most types of biological tissue. The enzyme complex will be used, for example, to treat a purulent surgical infection. A drug containing such enzymes will accelerate the removal of necrosis from the wound surface.